Abiopharma

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas

(30% Negative) INCANNEX HEALTHCARE INC. (IXHL) Announces Delay in Treatments Trials for Serious Mental Illness Due to Pandemic-Related Challenges, Regulatory Process, Safety Review

Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701

McKesson Corporation - McKesson Corporation Declares Quarterly Dividend

New Form DEF 14A - Consolidated Water Co. Ltd. <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001104659-26-046528 <b>Size:</b> 4 MB

(99% Neutral) SPECTRAL AI, INC. (MDAI) Announces Regulatory Update

(30% Negative) ORRSTOWN FINANCIAL SERVICES INC (ORRF) Reports Q2 2026 Financial Results

AGENCIA COMERCIAL SPIRITS LTD. (AGCC) Files Form 6-K

(10% Negative) TENAX THERAPEUTICS, INC. (TENX) Announces Delay in roles Trials for Tenax’s evolution Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations

CBL INTERNATIONAL LTD (BANL) Files Form 6-K

PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701

PMV Pharmaceuticals Announces Board Chair Transition

AAR and Woodward sign multi-year commercial distribution agreement

Innoviz Technologies Launches InnovizTwo Ultra Long-Range (ULR) LiDAR, Delivering up to 1-Kilometer Sensing to Power Next-Generation Physical AI for Automotive and SMART Applications